Skip to main content
Register for FutureLink Barcelona 2026 Today→
TraceLink — Network for Greater Good
AI Mode Agents AI Solutions Network Resources About
LOG IN TraceLink Classic OPUS Platform
Resources

Breadcrumb

  1. Home
  2. Resources
  3. Resource Center

DSCSA Governance Group Reveals 2023 Interoperability Blueprint

banner-image
  • Download PDF
  • Share
    • LinkedIn
    • Facebook
    • Mail
    • Twitter

Table of contents

Key takeaways

  • The PDG Blueprint signals the industry to start planning and budgeting to meet 2023 requirements. 
  • The Blueprint includes recommendations for serialized data exchange, interoperability, and trade partner authentication.
  • PDG recognizes “Direct-to-Source” verification of the product identifier against manufacturer data as an appropriate method of verification . “Direct-to-replicate” verification is recognized with limited applicability to specific circumstances.   Verification against the packaging itself is not seen as a viable alternative.
  • PDG will host public workshops to discuss the Blueprint and next steps toward successful implementation.

A critical step in achieving DSCSA interoperability

The Partnership for DSCSA Governance (PDG) is an industry consortium of more than 60 pharmaceutical supply chain stakeholders. Established in late 2019, PDG is a public-private partnership with the FDA “to establish and advance an industry consensus for an interoperable system to meet 2023 DSCSA requirements.” The DSCSA 2023 requirements comprise three interrelated statutory components that go into effect on November 27, 2023:

  • Interoperable Exchange. Trading partners must exchange required transaction information (TI) and transaction statements (TS) in a secure, electronic, interoperable manner, and the TI must include the product identifier at the package level.
  • Interoperable Verification. Trading partners must be able to verify the product identifier on a package or sealed homogeneous case in a secure, electronic, interoperable manner.
  • Interoperable Tracing. Trading partners must maintain secure, electronic, interoperable systems and processes to provide TI and TS in response to a request for it and to promptly facilitate gathering the information necessary to produce the TI for each transaction going back to the manufacturer.

On July 14, PDG released the first chapter of its consensus-based industry Blueprint for secure, electronic, interoperable unit-level tracing, verification, and reporting, as required under DSCSA. Chapter 1 of the Blueprint, “Understanding of Compliance Requirements and Baseline Business Requirements” comprises 5 sections:

  • Requirements and Recommendations to Support Serialized Transaction Information (TI) and Transaction Statement (TS) Data Exchange
  • Requirements and Recommendations to Support Interoperable Verification
  • Requirements and Recommendations to Support Interoperable Tracing
  • Requirements and Recommendations to Support Credentialing and Trading Partner Authentication
  • A glossary of industry and statutory terms

Addressing the authentication and verification challenge

The Blueprint provides a detailed, industry-driven foundation for meeting DSCSA interoperability requirements while achieving critical business requirements. It also represents an industry perspective on two outstanding issues regarding interoperable data exchange between trading partners:

  • Trade partner credentialing and authentication. While DSCSA requires that transactions only take place between “Authorized Trading Partners (ATP),” it does not provide a prescriptive method for authenticating a partner before initiating an electronic data exchange. In place of existing manual authentication processes, the PDG Blueprint describes a more robust and operationally efficient method using a verifiable ATP Credential for validating the identity and ATP status of the requester or responder.
  • Product verification method. The Blueprint assesses 3 options for meeting DSCSA verification requirements. While both “Direct-to-Source” and “Direct-to-Replicate” verification using product information provided by the manufacturer are recognized as appropriate methods of verification, “Direct-to-Replicate” is considered appropriate for certain specific circumstances listed in the PDG Blueprint requirements document. The third method, “Direct-to-Product” verification using data collected by the verifier by scanning the physical product, is not seen as an appropriate method for verification as defined under the statute.

PDG will host a series of public workshops to discuss the content of the Blueprint and next steps as industry works toward full compliance with the DSCSA 2023 requirements. The public workshops are open to all industry stakeholders.

The “starting gun” in the race to DSCSA 2023 interoperability

The PDG Blueprint signals the start of an industry-wide, cross-segment push to meet the final phase of DSCSA requirements. Because much of the solution design and development work is expected to take place in 2022, companies are advised to plan and budget accordingly for next year in order to be well positioned for implementation, testing, and “go-live” in 2023. Contact TraceLink to learn more and to schedule a consultative workshop.

 

<a href="/category/blog" hreflang="en">Blog</a><a href="/category/dscsa-dispensers" hreflang="en">DSCSA for Dispensers</a>, <a href="/category/dscsa-manufacturers" hreflang="en">DSCSA for Manufacturers</a><a href="/category/regulatory-compliance" hreflang="en">Regulatory/Compliance</a><a href="/region-type/united-states" hreflang="en">United States</a>

Table of contents

Contact TraceLink
Learn more about TraceLink's solutions for DSCSA 2023 compliance
 

Thank you for contacting us; we’ll be in touch shortly.

More Serialization and DSCSA Compliance Resources
dispenser_prescription_bottles_resource.jpg
How Serialization Empowers Health Systems to Improve Patient Care
Find out how the right approach to DSCSA compliance and serialization can lead directly to better patient outcomes.
View More
dispenser_bottles.jpg
DSCSA and the Path to Supply Chain Transformation for Retail Pharmacies
DSCSA isn't just a requirement for your retail pharmacy, it's an opportunity. Watch this supply chain transformation video to find out why.
View More

Cookie Settings

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies or similar tracking technologies. Please see below for an overview of the categories of cookies and similar technologies used on this site. You can allow or deny some of all of them, except Strictly Necessary Cookies which are required to provide the site to you. However, blocking some types of cookies may impact your experience of the site and services we are able to offer.

Please see our Cookie Policy for more details, including a list of the cookies we use. You can change your consent options at any time by following the “Cookie Settings” link in the Cookie Policy.
'Strictly Necessary' cookies let you move around the Site and use essential features like secure areas, shopping baskets and online billing. Without these cookies you would not be able to navigate between pages or use certain vital features of our Site, so we do not require your consent for their use. These cookies don't gather any information about you that could be used for marketing or remembering where you've been on the internet. For example, we use these Strictly Necessary cookies to identify you as being logged in to the Site. You can set your browser to block or alert you about these cookies, but if you do so, some parts of the Site will not work.
'Performance' cookies collect information about how you use the Site, such as which pages you visit, the time spent on the Site and if you experience any errors. We use performance cookies to provide aggregated statistics on how the Site is used and help us improve the Site including by measuring any errors that occur.
'Functional' cookies are used to provide services or to remember settings to improve your visit. We use 'Functionality' cookies to remember your settings and choices and show you when you're logged in to the Site.
‘Targeting' cookies are linked to services provided by third parties, such as 'Like' buttons and 'Share' buttons. The third party provides these services in return for recognizing that you have visited the Site. We also use 'Targeting' cookies to gather information that could be used to display content that we think may interest you.
Register for FutureLink Barcelona 2026 Today→
TraceLink — Network for Greater Good
Log In OPUS Platform · TraceLink Classic
AI Mode
Featured Report The Agentic Supply Chain Operating Model →

Agentic Business Processes

External Manufacturing Logistics Transportation Commerce Compliance

Products

Digital Transaction Exchange Process Collaboration Global Track-and-Trace Regulatory Compliance Real-Time Intelligence

Resources

Resource Center TraceLink University Partners Community Customers Events

About TraceLink

Newsroom Culture & Careers Open Jobs Legal & Trust Center Corporate Social Responsibility Network Directory Glossary

Hot Topics

Eliminate Stockouts Improve OTIF Reduce Costs Increase End-to-End Visibility Accelerate Order-to-Cash Optimize Inventory Levels Scale Cross-Partner Execution
Need assistance? Contact Technical Support→

Contact Us Today

Transform your supply chain operations with a human-agent workforce.

Contact Us →

Stay Up-to-Date

Subscribe to receive industry insights and evolving trends.

Thanks — you're subscribed.

© TraceLink Inc. 2009–2026 All Rights Reserved